Antimicrobial Stewardship (eBook)
CABI (Verlag)
978-1-78639-053-0 (ISBN)
In an age where antimicrobial resistance amongst pathogens grows more prevalent, particularly in the hospital setting, antimicrobial stewardship is an evidence-based, proven measure in the battle against resistance and infection.
This single comprehensive, definitive reference work is written by an international team of acknowledged experts in the field. The authors explore the effective use of coordinated antimicrobial interventions to change prescribing practice and help slow the emergence of antimicrobial resistance, ensuring that antimicrobials remain an effective treatment for infection.
Amongst the first of its kind, this book provides infectious disease physicians, administrators, laboratory, pharmacy, nursing and medical staff with practical guidance in setting up antimicrobial stewardship programs in their institutions with the aim of selecting the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration.
Eleftherios Mylonakis is a physician-scientist and his work focuses on the study of microbial pathogenesis and drug discovery. His research has developed a novel alternative to studying bacterial and fungal infection and host responses: the use of invertebrate model hosts. These surrogate invertebrate hosts fill an important niche in fungal pathogenesis research. His investigations have identified novel virulence factors, cross kingdom pathogen-pathogen interactions, novel antifungal agents and evolutionarily conserved traits that are involved in host virulence and immune responses during infection. Recently, Dr. Mylonakis implemented high-throughput whole-animal Caenorhabditis elegans assay to screen libraries of chemical compounds and identify those with antimicrobial activity. In vivo evaluation of libraries of chemical compounds could solve some of the main obstacles in current antifungal discovery, such as finding new classes of compounds and solving the bottleneck of toxicity/efficacy testing. This approach challenges the position that studies in fungal pathogenesis should focus on the analysis of the "host", the "pathogen", or the "antimicrobial compound".<br><br> Dr. Mylonakis has published over 150 articles in the scientific literature and his studies have been supported by peer-reviewed grants from the National Institutes of Health and private foundations. He is the founding Editor-in-Chief of the journal Virulence and serves on the editorial boards of many publications and as an ad hoc reviewer for over 40 journals.
| Erscheint lt. Verlag | 23.12.2016 |
|---|---|
| Co-Autor | Thomas Lodise, John McNelis, Powel Kazanjian, Armen Arshakyan, Cesar Arias, Allison H. Bartlett, Andrew Berti, April Bobenchik, Hugh Booth, Carey-Ann Burnham, Michael Calderwood, Gerald Capraro, Joseph Carreno, Kimberle Chapin, Christopher W Crank, Robert S. Daum, Susan Davis, George Daikos, Tom Dilworth, Christopher D Doern, Gary V Doern, Curtis Donskey, Monica Dorobisz, Ramy Elshaboury, Sandy Estrada, Islam Ghazi, Jennifer Goldman, Blanca Gonzalez, Christopher J Graber, Inge Gyssens, Sajeev Handa, Amy Hanson, Emily L Heil, Elizabeth D Hermsen, Styliani Karanika, Keith S Kaye, Joseph L Kuti, Nicole M Mahoney, Antonis Markogiannakis, Aileen Martinez, Dmitriy Martirosov, Dayna McManus, Renee-Claude Mercier, Jacob Morton, Jose M Munita, Jason Newland, David Nicolau, Jessica Ortwine, Suresh Paudel, Jason Pogue, Warren Rose, John Rotschafer, Michael Ruggero, Michael Samarkos, Nikolaos Sipsas, Harold Standiford, Melvin Stone, Mahlet Tadele, Evangelia Theophano Piperaki, Philip Toltzis, Jeffrey E Topal, Damary Torres, Leonidas Tzouvelekis, Jamie L Wagner, Carla Walraven, Panayiotis Ziakas |
| Verlagsort | Oxford |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| ISBN-10 | 1-78639-053-1 / 1786390531 |
| ISBN-13 | 978-1-78639-053-0 / 9781786390530 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich